Healthcare biotech; currently trading ~47% above its initial offering.
The 2026 IPO market has opened with its strongest first quarter since 2021, driven by high demand for AI-related infrastructure and fintech. While many recent debuts have been volatile, several high-profile companies from 2025 and 2026 are showing strong fundamentals or have received bullish analyst ratings. 🚀 Top Recent IPOs to Watch
Valued at roughly $134 billion; a leader in data and AI platforms.
The "Buy Now, Pay Later" giant went public in late 2025. Several major institutions like Deutsche Bank and Bank of America have since issued "Buy" ratings with price targets ranging from $48 to $51.
Analysis of IPOs with upcoming clinical trial milestones?
Leading GenAI firms rumored to be weighing public debuts this year.